| Outcomes . | n (%) . |
|---|---|
| . | (Total n = 174) . |
| Length of stay (mean, days) | 23.0 ± 18.2 |
| Microsurgical clipping | 16 (9.2) |
| Endovascular treatment | 108 (62.1) |
| Aneurysm rerupture during hospitalization | 10 (5.7) |
| Sustained intracranial pressure crisis | 22 (12.6) |
| Respiratory failure | 77 (44.2) |
| Vasospasm (detected radiographically or clinically) | 61 (35.0) |
| Decompression for cerebral edema/intracranial pressure crisis | 13 (7.5) |
| Norepinephrine use | 57 (32.8) |
| Ventriculoperitoneal shunt | 26 (14.9) |
| Tracheostomy | 23 (13.2) |
| Discharge mRSa >2 | 67 (38.5) |
| Three-month mRSa >2 | 42 (24.1) |
| In-hospital mortality | 28 (16.1) |
| Outcomes . | n (%) . |
|---|---|
| . | (Total n = 174) . |
| Length of stay (mean, days) | 23.0 ± 18.2 |
| Microsurgical clipping | 16 (9.2) |
| Endovascular treatment | 108 (62.1) |
| Aneurysm rerupture during hospitalization | 10 (5.7) |
| Sustained intracranial pressure crisis | 22 (12.6) |
| Respiratory failure | 77 (44.2) |
| Vasospasm (detected radiographically or clinically) | 61 (35.0) |
| Decompression for cerebral edema/intracranial pressure crisis | 13 (7.5) |
| Norepinephrine use | 57 (32.8) |
| Ventriculoperitoneal shunt | 26 (14.9) |
| Tracheostomy | 23 (13.2) |
| Discharge mRSa >2 | 67 (38.5) |
| Three-month mRSa >2 | 42 (24.1) |
| In-hospital mortality | 28 (16.1) |
Abbreviation: SAH, subarachnoid hemorrhage.
aModified Rankin score.
| Outcomes . | n (%) . |
|---|---|
| . | (Total n = 174) . |
| Length of stay (mean, days) | 23.0 ± 18.2 |
| Microsurgical clipping | 16 (9.2) |
| Endovascular treatment | 108 (62.1) |
| Aneurysm rerupture during hospitalization | 10 (5.7) |
| Sustained intracranial pressure crisis | 22 (12.6) |
| Respiratory failure | 77 (44.2) |
| Vasospasm (detected radiographically or clinically) | 61 (35.0) |
| Decompression for cerebral edema/intracranial pressure crisis | 13 (7.5) |
| Norepinephrine use | 57 (32.8) |
| Ventriculoperitoneal shunt | 26 (14.9) |
| Tracheostomy | 23 (13.2) |
| Discharge mRSa >2 | 67 (38.5) |
| Three-month mRSa >2 | 42 (24.1) |
| In-hospital mortality | 28 (16.1) |
| Outcomes . | n (%) . |
|---|---|
| . | (Total n = 174) . |
| Length of stay (mean, days) | 23.0 ± 18.2 |
| Microsurgical clipping | 16 (9.2) |
| Endovascular treatment | 108 (62.1) |
| Aneurysm rerupture during hospitalization | 10 (5.7) |
| Sustained intracranial pressure crisis | 22 (12.6) |
| Respiratory failure | 77 (44.2) |
| Vasospasm (detected radiographically or clinically) | 61 (35.0) |
| Decompression for cerebral edema/intracranial pressure crisis | 13 (7.5) |
| Norepinephrine use | 57 (32.8) |
| Ventriculoperitoneal shunt | 26 (14.9) |
| Tracheostomy | 23 (13.2) |
| Discharge mRSa >2 | 67 (38.5) |
| Three-month mRSa >2 | 42 (24.1) |
| In-hospital mortality | 28 (16.1) |
Abbreviation: SAH, subarachnoid hemorrhage.
aModified Rankin score.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
